Sarcoma & GIST
Reports from the annual meeting of The Connective Tissue Society held November 14-18, 2018, in Rome.
Reports from the annual meeting of The Connective Tissue Oncology Society held in Rome, November 14-17, 2018 Sarcoma of the Year: Intimal Sarcoma
Sarcoma of the Year: Intimal Sarcoma
Larotrectinib is approved for patients with solid tumors that have progressed following treatment and harbor a NTRK gene fusion without a...
From the Journals
Tyrosine kinase inhibitors and immune checkpoint inhibitors show encouraging results in the treatment of alveolar soft part sarcoma
Aberrations in oncogenic pathways and immune modulation influence treatment response in patients with metastatic leiomyosarcoma or liposarcoma.
The partial hold that paused U.S.-based enrollment in clinical trials of tazemetostat has been lifted.